Impact of Surgical Margin in Skull Base Surgery for Head and Neck Sarcomas

Abstract

Objective This study aimed to determine the adequate resection margin in skull base surgery for head and neck sarcoma.

Design We retrospectively reviewed 22 sarcomas with skull base invasion. Induction chemotherapy, followed by surgery and postoperative radiotherapy and adjuvant chemotherapy, was performed in 18 patients with chemosensitive sarcomas, and surgery with or without postoperative radiotherapy was performed in four patients with chemoresistant sarcomas. Radical resection was performed in patients with chemosensitive sarcomas with a poor response to induction chemotherapy and in patients with chemoresistant sarcomas. Conservative resection with close surgical margin was performed in patients with chemosensitive sarcomas with a good response to induction chemotherapy.

Setting and Participants This single-centered retrospective study included patients from the National Cancer Center Hospital, Japan.

Results The response to induction chemotherapy was significantly associated with the 3-year local control rate (LCR; good response versus poor response: 100% versus 63%, p = 0.048). Patients with a good response to chemotherapy had a favorable local prognosis even when the local therapy was conservative resection. In radical skull base surgery, patients whose surgical margins were classified as “wide margin positive” had significantly poorer 3-year LCR than did patients with “margin negative” or “micro margin positive” margins (25% versus 83%, p = 0.014).

Conclusion Conservative resection with close surgical margins might be acceptable for chemosensitive sarcomas with a good response to chemotherapy. Resection margin status was an important predictive factor for local recurrence after radical skull base surgery. Microscopic microresidual tumor might be controlled by postoperative treatment.

Keywords

head and neck sarcoma - skull base surgery - surgical margin - induction chemotherapy - chemosensitivity

• References

• 1 Montogomery PQ, Evans PHR, Gullane PJ. Principles and Practice of Head and Neck Surgery and Oncology. 2nd ed. London: Informa; 2009
• 2 Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol 2002; 15 (03) 324-330
• 3 O'Sullivan B, Bell RS, Bramwell VHC. Sarcomas of the soft tissue. In: Souhami RL, Tannock I, Hohenberger P. , et al., eds. Oxford Textbook of Oncology, 2nd ed. Oxford: Oxford University Press; 2002: 2495-2523
• 4 Arndt CA, Stoner JA, Hawkins DS. , et al. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803. J Clin Oncol 2009; 27 (31) 5182-5188
• 5 Grier HE, Krailo MD, Tarbell NJ. , et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348 (08) 694-701
• 6 Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer 2012; 59 (01) 5-10
• 7 Rodeberg DA, Wharam MD, Lyden ER. , et al. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Int J Cancer 2015; 137 (01) 204-211
• 8 Kobayashi K, Matsumoto F, Kodaira M. , et al. Significance of delayed primary excision in localized nonmetastatic adult head and neck rhabdomyosarcoma. Cancer Med 2016; 5 (10) 2708-2714
• 9 Ohno K, Tsunoda A, Shirakura S, Takahashi N, Kishimoto S. The approaches and outcomes of skull base surgery for pediatric sarcoma after initial therapy. Auris Nasus Larynx 2011; 38 (02) 208-214
• 10 Bentz BG, Bilsky MH, Shah JP, Kraus D. Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head Neck 2003; 25 (07) 515-520
• 11 Kawahara N, Sasaki T, Asakage T. , et al. Long-term outcome following radical temporal bone resection for lateral skull base malignancies: a neurosurgical perspective. J Neurosurg 2008; 108 (03) 501-510
• 12 Crist WM, Anderson JR, Meza JL. , et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12) 3091-3102
• 13 Spalding AC, Hawkins DS, Donaldson SS. , et al. The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803. Int J Radiat Oncol Biol Phys 2013; 87 (03) 512-516